Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
OPDP
Marketing
Novartis earns FDA ire for ‘misleading’ Fabhalta ad imagery
The FDA is not feeling the love in a commercial for Novartis’ paroxysmal nocturnal hemoglobinuria treatment Fabhalta.
Andrea Park
Sep 30, 2025 11:12am
Sprout hit with FDA warning letter over CEO’s Instagram post
Jun 12, 2025 12:00pm
Senator probes FDA drug ad regulation after OPDP cuts
May 30, 2025 10:10am
FDA ad watchers take umbrage at Xeris' 'misleading claims'
Jun 14, 2023 9:15am
FDA to study how patients, physicians choose prescription drugs
Apr 26, 2022 10:55am
Good ad or bad ad? FDA reminds docs about its Bad Ad program
Sep 20, 2021 11:46am
